MeiraGTx Holdings Plc (MGTX)
13.25
+0.20
(+1.53%)
USD |
NASDAQ |
Sep 18, 16:00
13.25
0.00 (0.00%)
After-Hours: 20:00
MeiraGTx Holdings Cash from Operations (Quarterly) : -38.54M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -38.54M |
| March 31, 2026 | 17.81M |
| December 31, 2025 | 46.63M |
| September 30, 2025 | -12.22M |
| June 30, 2025 | -43.95M |
| March 31, 2025 | -36.83M |
| December 31, 2024 | -23.28M |
| September 30, 2024 | -25.02M |
| June 30, 2024 | -19.46M |
| March 31, 2024 | -36.74M |
| December 31, 2023 | -14.55M |
| September 30, 2023 | -24.41M |
| June 30, 2023 | -29.01M |
| March 31, 2023 | -37.39M |
| December 31, 2022 | |
| September 30, 2022 | -20.73M |
| June 30, 2022 | -27.81M |
| March 31, 2022 | -8.298M |
| December 31, 2021 | 18.83M |
| Date | Value |
|---|---|
| September 30, 2021 | -17.18M |
| June 30, 2021 | -21.26M |
| March 31, 2021 | 9.086M |
| December 31, 2020 | -29.56M |
| September 30, 2020 | -9.142M |
| June 30, 2020 | -12.88M |
| March 31, 2020 | -12.38M |
| December 31, 2019 | -21.97M |
| September 30, 2019 | -18.41M |
| June 30, 2019 | -21.74M |
| March 31, 2019 | 82.17M |
| December 31, 2018 | -11.47M |
| September 30, 2018 | -10.99M |
| June 30, 2018 | -19.03M |
| March 31, 2018 | -17.40M |
| December 31, 2017 | |
| September 30, 2017 | -3.815M |
| June 30, 2017 | -4.135M |
| March 31, 2017 | -6.395M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Xencor, Inc. | -55.66M |
| UroGen Pharma Ltd. | -35.02M |
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Viking Therapeutics, Inc. | -125.17M |
| IDEAYA Biosciences, Inc. | -88.21M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -23.63M |
| Cash from Financing (Quarterly) | 133.89M |
| Free Cash Flow | 10.06M |
| Free Cash Flow Per Share (Quarterly) | -0.4144 |
| Free Cash Flow to Equity (Quarterly) | -63.66M |
| Free Cash Flow to Firm (Quarterly) | -35.41M |
| Free Cash Flow Yield | 0.90% |